ImmunoGen Inc (IMGN)

[XenaLives]

Blackrock - it figures....

BlackRock Inc. discloses 8.30% ownership in IMGN / Immunogen, Inc.

February 04, 2019 - BlackRock Inc. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,378,204 shares of Immunogen, Inc. (NASDAQ:IMGN). This represents 8.3 percent ownership of the company. In their previous filing dated February 01, 2018, BlackRock Inc. had reported owning 8,493,975 shares, indicating an increase of 45.73 percent.

Other investors with positions similar to BlackRock Inc. include Redmile Group, LLC, and Vanguard Group Inc.

Immunogen, Inc. has declared a standard industrial code (sic) of 2834 which is the "Pharmaceutical Preparations" industry. BlackRock Inc.'s top industries are "Legal Services" (sic 81), "Miscellaneous Repair Services" (sic 76), and "Agriculture production livestock and animal specialties" (sic 02).

https://fintel.io/soh/us/imgn/blackrock